-
EP0234545
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP0234545
| EP0234545 - Purified human angiogenic factor, method for its preparation and pharmaceutical preparations [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 13.05.1992 Database last updated on 02.11.2024 | Most recent event Tooltip | 13.05.1992 | Application deemed to be withdrawn | published on 01.07.1992 [1992/27] | Applicant(s) | For all designated states Sorg, Clemens, Prof. Dr. Alhardstrasse 21 D-4400 Münster-Nienberge / DE | [1988/32] |
| Former [1987/36] | For all designated states Robapharm AG St. Albanrheinweg 174 CH-4006 Basel / CH | Inventor(s) | 01 /
see applicant ... | [1988/33] |
| Former [1987/36] | 01 /
Sorg, Clemens, Prof. Dr. Alhardstrasse 21 D-4400 Münster-Nienberge / DE | Representative(s) | Vossius & Partner Patentanwälte Rechtsanwälte mbB Siebertstrasse 3 81675 München / DE | [N/P] |
| Former [1987/36] | VOSSIUS & PARTNER Postfach 86 07 67 D-81634 München / DE | Application number, filing date | 87102550.8 | 23.02.1987 | [1987/36] | Priority number, date | DE19863605907 | 24.02.1986 Original published format: DE 3605907 | [1987/36] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | EP0234545 | Date: | 02.09.1987 | Language: | EN | [1987/36] | Type: | A3 Search report | No.: | EP0234545 | Date: | 24.05.1989 | Language: | EN | [1989/21] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 05.04.1989 | Classification | IPC: | C07K15/06, C07K3/18, C12P21/00, C07K3/28, A61K37/02, A61K35/12, // (C12P21/00, C12R1:91) | [1987/36] | CPC: |
C07K16/22 (EP);
A61P43/00 (EP);
A61P9/14 (EP);
C07K14/515 (EP);
A61K38/00 (EP)
| Designated contracting states | AT, BE, CH, DE, ES, FR, GB, GR, IT, LI, LU, NL, SE [1987/36] | Title | German: | Gereinigter humaner Angiogenfaktor, Verfahren zu seiner Herstellung und pharmazeutische Präparate | [1987/36] | English: | Purified human angiogenic factor, method for its preparation and pharmaceutical preparations | [1987/36] | French: | Facteur angiogénique humain purifié, procédé pour sa préparation et préparations pharmaceutiques | [1987/36] | File destroyed: | 12.06.1999 | Examination procedure | 15.11.1989 | Examination requested [1990/02] | 09.08.1991 | Despatch of a communication from the examining division (Time limit: M04) | 20.12.1991 | Application deemed to be withdrawn, date of legal effect [1992/27] | 22.01.1992 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [1992/27] | Fees paid | Renewal fee | 27.02.1989 | Renewal fee patent year 03 | 23.02.1990 | Renewal fee patent year 04 | 27.02.1991 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 02.03.1992 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [Y]US4529590 (LEVEEN ROBERT F [US], et al); | [E]WO8606079 (HARVARD COLLEGE [US]) | [Y] - BIOCHEMISTRY, vol. 24, 1985, pages 5480-5486, American Chemical Society; J.W. FETT et al.: "Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells" | [Y] - BIOLOGICAL ABSTRACT, vol. 67, no. 11, 1979, page 6719, abstract no. 67274, Philadelphia, PA, US; K. NISHIOKA et al.: "Angicgemic activity in culture supermatant of antiges-stimulated lymph mode cells", & J. PATHOL 126(2): 63-70. 1978 |